RAYTECH HOLDING LTD (RAY)

VGG7385S1011 - Common Stock

1.89  -0.01 (-0.53%)

Premarket: 1.98 +0.09 (+4.76%)

Fundamental Rating

6

RAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 14 industry peers in the Distributors industry. RAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, RAY is valued expensive at the moment.



6

1. Profitability

1.1 Basic Checks

In the past year RAY was profitable.
In the past year RAY had a positive cash flow from operations.

1.2 Ratios

RAY has a Return On Assets of 28.14%. This is amongst the best in the industry. RAY outperforms 100.00% of its industry peers.
The Return On Equity of RAY (52.63%) is better than 100.00% of its industry peers.
The Return On Invested Capital of RAY (47.78%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RAY is significantly above the industry average of 13.94%.
The 3 year average ROIC (38.47%) for RAY is below the current ROIC(47.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 28.14%
ROE 52.63%
ROIC 47.78%
ROA(3y)27.12%
ROA(5y)N/A
ROE(3y)41.78%
ROE(5y)N/A
ROIC(3y)38.47%
ROIC(5y)N/A

1.3 Margins

The Profit Margin of RAY (16.36%) is better than 100.00% of its industry peers.
RAY's Profit Margin has declined in the last couple of years.
RAY has a Operating Margin of 18.32%. This is amongst the best in the industry. RAY outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of RAY has declined.
The Gross Margin of RAY (23.62%) is worse than 61.54% of its industry peers.
In the last couple of years the Gross Margin of RAY has declined.
Industry RankSector Rank
OM 18.32%
PM (TTM) 16.36%
GM 23.62%
OM growth 3Y-7.01%
OM growth 5YN/A
PM growth 3Y-5.63%
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so RAY is creating value.
The number of shares outstanding for RAY has been reduced compared to 1 year ago.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

RAY has an Altman-Z score of 9.80. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RAY (9.80) is better than 100.00% of its industry peers.
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.8
ROIC/WACC3.7
WACC12.9%

2.3 Liquidity

RAY has a Current Ratio of 1.95. This is a normal value and indicates that RAY is financially healthy and should not expect problems in meeting its short term obligations.
RAY has a Current ratio (1.95) which is in line with its industry peers.
A Quick Ratio of 1.89 indicates that RAY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.89, RAY belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.89

5

3. Growth

3.1 Past

RAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.83%, which is quite impressive.
RAY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.56% yearly.
RAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 56.28%.
Measured over the past years, RAY shows a very strong growth in Revenue. The Revenue has been growing by 28.10% on average per year.
EPS 1Y (TTM)109.83%
EPS 3Y24.56%
EPS 5YN/A
EPS Q2Q%72.71%
Revenue 1Y (TTM)56.28%
Revenue growth 3Y28.1%
Revenue growth 5YN/A
Sales Q2Q%47.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.54, which indicates a correct valuation of RAY.
69.23% of the companies in the same industry are more expensive than RAY, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 30.45. RAY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.54
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RAY is on the same level as its industry peers.
RAY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 14.06
EV/EBITDA 12.2

4.3 Compensation for Growth

The decent profitability rating of RAY may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RAY!.
Industry RankSector Rank
Dividend Yield N/A

RAYTECH HOLDING LTD

NASDAQ:RAY (9/18/2024, 8:24:57 PM)

Premarket: 1.98 +0.09 (+4.76%)

1.89

-0.01 (-0.53%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap33.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.54
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 28.14%
ROE 52.63%
ROCE
ROIC
ROICexc
ROICexgc
OM 18.32%
PM (TTM) 16.36%
GM 23.62%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.95
Quick Ratio 1.89
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)109.83%
EPS 3Y24.56%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)56.28%
Revenue growth 3Y28.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y